BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28957971)

  • 21. Clostridium difficile Infection and Fecal Microbiota Transplant.
    Liubakka A; Vaughn BP
    AACN Adv Crit Care; 2016 Jul; 27(3):324-337. PubMed ID: 27959316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
    J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study.
    Staley C; Hamilton MJ; Vaughn BP; Graiziger CT; Newman KM; Kabage AJ; Sadowsky MJ; Khoruts A
    Am J Gastroenterol; 2017 Jun; 112(6):940-947. PubMed ID: 28195180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.
    Fischer M; Kao D; Mehta SR; Martin T; Dimitry J; Keshteli AH; Cook GK; Phelps E; Sipe BW; Xu H; Kelly CR
    Am J Gastroenterol; 2016 Jul; 111(7):1024-31. PubMed ID: 27185076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
    Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin.
    Konturek PC; Haziri D; Helfritzsch H; Hess T; Harsch IA
    Med Princ Pract; 2017; 26(2):182-184. PubMed ID: 27978522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of toxic megacolon caused by clostridium difficile infection and treated with fecal microbiota transplantation.
    Gweon TG; Lee KJ; Kang DH; Park SS; Kim KH; Seong HJ; Ban TH; Moon SJ; Kim JS; Kim SW
    Gut Liver; 2015 Mar; 9(2):247-50. PubMed ID: 25721003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent
    Song JH; Kim YS
    Gut Liver; 2019 Jan; 13(1):16-24. PubMed ID: 30400734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe.
    Tacke D; Wisplinghoff H; Kretzschmar A; Farowski F; Koehler P; Herweg J; Cornely OA; Vehreschild MJ
    Clin Microbiol Infect; 2015 Nov; 21(11):e82-4. PubMed ID: 26163107
    [No Abstract]   [Full Text] [Related]  

  • 33. Fecal microbiota transplantation in the treatment of Clostridium difficile infections.
    Austin M; Mellow M; Tierney WM
    Am J Med; 2014 Jun; 127(6):479-83. PubMed ID: 24582877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series.
    Hefazi M; Patnaik MM; Hogan WJ; Litzow MR; Pardi DS; Khanna S
    Mayo Clin Proc; 2017 Nov; 92(11):1617-1624. PubMed ID: 29101931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A different kind of "allogeneic transplant": successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma.
    Trubiano JA; George A; Barnett J; Siwan M; Heriot A; Prince HM; Slavin MA; Teh BW
    Leuk Lymphoma; 2015 Feb; 56(2):512-4. PubMed ID: 24828871
    [No Abstract]   [Full Text] [Related]  

  • 36. Fecal microbiota transplantation in the treatment of Clostridium difficile infection: state of the art and literature review.
    Messias BA; Franchi BF; Pontes PH; Barbosa DÁAM; Viana CAS
    Rev Col Bras Cir; 2018; 45(2):e1609. PubMed ID: 29846464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal microbiota transplantation via nasogastric tube for recurrent clostridium difficile infection in pediatric patients.
    Kronman MP; Nielson HJ; Adler AL; Giefer MJ; Wahbeh G; Singh N; Zerr DM; Suskind DL
    J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):23-6. PubMed ID: 25162365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fidaxomicin and Fecal Microbiota Transplants for Severe Clostridium difficile Colitis.
    Mankal PK; Abed J; Latte-Naor S; Grinspan A; Kotler DP
    Am J Ther; 2019; 26(1):e115-e117. PubMed ID: 30601771
    [No Abstract]   [Full Text] [Related]  

  • 39. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Fischer M; Kao D; Kelly C; Kuchipudi A; Jafri SM; Blumenkehl M; Rex D; Mellow M; Kaur N; Sokol H; Cook G; Hamilton MJ; Phelps E; Sipe B; Xu H; Allegretti JR
    Inflamm Bowel Dis; 2016 Oct; 22(10):2402-9. PubMed ID: 27580384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Faecal microbiota transplantation: Key points to consider.
    Bourlioux P;
    Ann Pharm Fr; 2015 May; 73(3):163-8. PubMed ID: 25747146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.